---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-23-037159"
form_type: "8-K"
ticker: "INFU"
cik: "0001337013"
company_name: "InfuSystem Holdings, Inc"
filed_at: "2023-11-07T23:59:59+00:00"
generated_at: "2026-06-08T14:06:08.863219+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# InfuSystem Q3 revenue $31.9M (+17% YoY), net income up 56%, raises FY 2023 guidance

## Summary
- Net revenues $31.9M (+17% YoY); net income $0.7M ($0.03 diluted EPS) vs $0.4M prior year.
- Adjusted EBITDA $6.2M (+11% YoY); FY 2023 net revenue growth guidance raised to >11% (from >10%).
- Patient Services revenue $19.3M (+11%), Device Solutions $12.6M (+27%); gross margin fell to 50.9% from 59.5%.
- Operating income increased 80%; record revenue for seventh consecutive quarter.

## SEC filing metadata
- accession: 0001628280-23-037159
- form_type: 8-K
- ticker: INFU
- cik: 0001337013
- company_name: InfuSystem Holdings, Inc
- filed_at: 2023-11-07T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1337013/000162828023037159/0001628280-23-037159-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1337013/000162828023037159/infu-20231107.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-23-037159
- JSON: https://secwatch.observer/filing/0001628280-23-037159.json
- Plain text: https://secwatch.observer/filing/0001628280-23-037159.txt

## Key facts
- Earnings Releases
  InfuSystem Holdings, Inc reported third quarter ended September 30, 2023 results: revenue $31.9 million, net income $0.7 million, or $0.03 per diluted share, EPS $0.03 per diluted share. Guidance raised.
  - Period: third quarter ended September 30, 2023
  - Revenue: $31.9 million
  - Net income: $0.7 million, or $0.03 per diluted share
  - EPS: $0.03 per diluted share
  - Guidance: raised
  - Result: reported results
  source text: InfuSystem Reports Third Quarter 2023 Financial Results Record Net Revenues of $31.9 million Representing 17% Growth from the Prior Year
  evidence_url: https://www.sec.gov/Archives/edgar/data/1337013/000162828023037159/0001628280-23-037159-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.